Sun Pharmaceutical Industries Limited
Sun Pharmaceutical Industries Ltd is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulations and Active Pharma Ingredients (APIs). The company and its subsidiaries has various manufacturing facilities spread across the world with trading and other incidental and related activities extending to global market.It is the largest pharmaceutical company in India.
What Sun files
- Others66
- Updates46
- Investor Meet43
- Important26
- Dividend/Bonus8
- PPTs7
Sun Pharmaceutical Industries Limited has informed the Exchange about Incorporation of a Subsidiary Company
Sun Pharmaceutical Industries Limited has informed the Exchange about International Credit Ratings
Sun Pharmaceutical Industries will participate in multiple analyst/institutional investor meetings in September, including the UBS India Summit, Jefferies India Forum, Kotak Institutional Equities Healthcare Forum, J.P. Morgan India Conference, and Anand Rathi Annual Flagship Conference G-200 Summit. These will be physical group and one-on-one interactions.
Sun Pharma committed to Most Favored Nation (MFN) pricing for US Medicaid and future innovative medicines. In return, it secured a two-year delay on Section 232 tariffs for innovative pharmaceutical products, aiding US patients and benefiting the company.